NEWS

VHIO’s Paolo Nuciforo first authors study of predictive model to gauge response to treatment without chemotherapy in HER2+ breast cancer patients

Paolo Nuciforo, Principal Investigator of VHIO's Molecular Oncology Group [...]

14/11/2017|